Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




MD HPLC, MD Mass Spec, and Software Receive IVDD CE-Marking

By LabMedica International staff writers
Posted on 15 Sep 2015
The in vitro diagnostics device (IVDD) CE marking for the two high-performance instruments and software enables a combined system with the high accuracy of LC-MS to now be available to clinical laboratories in Europe for general IVD use.

Thermo Fisher Scientific (Waltham, MA, USA) has received the CE marking for its Thermo Scientific Prelude MD HPLC, Endura MD mass spectrometer, and ClinQuan MD software. More...
Clinical laboratories in Europe now have access to a high-performance liquid chromatograph, mass spectrometer, and LC-MS software designed and manufactured for analyzing patient samples as components of laboratory-developed IVD tests.

"We're strongly committed to bringing the advantages of LC-MS to the clinical market," said Bradley Hart, strategic director, life sciences mass spectrometry, clinical markets, Thermo Fisher, “These three products are part of a larger initiative to make mass spectrometry more useful and accessible to clinicians.”

The Prelude MD HPLC provides automated sample cleanup and two channels of HPLC separation for greater productivity and certainty from laboratory-developed clinical diagnostic tests. Developing IVD tests with the Endura MD MS provides excellent sensitivity, quantitative performance, and robustness with built-in usability to help deliver more value and worry-free results.

The products were exhibited at the 2nd Annual European Conference on Clinical Mass Spectrometry, MSACL EU 2015 (September 8-11, Salzburg, Austria).

Related Links:

Thermo Fisher Scientific
Thermo Fisher Posters & Products presented at MSACL EU 2015
MSACL EU 2015 Conference 



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: A new study links broad genomic sequencing before first-line therapy to longer survival, supporting its role in treatment decisions (Image Credit: Shutterstock)

Study Supports Broad Genomic Profiling Before First-Line Lung Cancer Treatment

Biomarker testing plays a critical role in advanced non-small cell lung cancer by identifying patients who may benefit from targeted therapies. However, testing only one or two genes can miss actionable... Read more

Immunology

view channel
Image: The findings underscore the importance of aligning allergy testing with clinical history and diagnostic guidelines to reduce inappropriate testing and its consequences (Image Credit: iStock)

Survey Finds Gap Between Food Allergy Testing Awareness and Clinical Practice

Food allergy evaluation can be challenging when laboratory results do not match clinical symptoms. Broad food allergy panels may detect sensitization without confirming an actual allergy, potentially leading... Read more

Industry

view channel
Image Credit: iStock

C2N Makes PrecivityAD2 Alzheimer’s Blood Test Available to Clinicians

Diagnosing Alzheimer’s disease can be challenging, particularly in patients with mild cognitive impairment or early dementia. Assessing brain amyloid pathology can guide clinical decisions, but diagnostic... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.